DPP4 and atherosclerosis: Furthermore, dipeptidyl peptidase 4 (DPP4) has an inflammatory role in the pathogenesis of atherosclerosis and ACS therefore, DPP4 inhibitors such as sitagliptin reduce the severity of ACS in diabetic patients.